Skip to main content

Rabbit Recombinant Monoclonal MARK4 phospho T214 + MARK2 phospho T208 + MARK3 phospho T234 + MARK1 phospho T215 antibody. Suitable for Dot, WB, I-ELISA and reacts with Human amd Synthetic peptide samples.

Be the first to review this product! Submit a review

Images

Western blot - Anti-MARK4 (phospho T214) + MARK2 (phospho T208) + MARK3 (phospho T234) + MARK1 (phospho T215) antibody [EPR5463] (AB126731), expandable thumbnail
  • Indirect ELISA - Anti-MARK4 (phospho T214) + MARK2 (phospho T208) + MARK3 (phospho T234) + MARK1 (phospho T215) antibody [EPR5463] (AB126731), expandable thumbnail
  • Dot Blot - Anti-MARK4 (phospho T214) + MARK2 (phospho T208) + MARK3 (phospho T234) + MARK1 (phospho T215) antibody [EPR5463] (AB126731), expandable thumbnail
  • Western blot - Anti-MARK4 (phospho T214) + MARK2 (phospho T208) + MARK3 (phospho T234) + MARK1 (phospho T215) antibody [EPR5463] (AB126731), expandable thumbnail
  • OI-RD Scanning - Anti-MARK4 (phospho T214) + MARK2 (phospho T208) + MARK3 (phospho T234) + MARK1 (phospho T215) antibody [EPR5463] (AB126731), expandable thumbnail

Key facts

Isotype
IgG
Host species
Rabbit
Storage buffer

pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9% PBS, 0.05% BSA

Form
Liquid
Clonality
Monoclonal

Immunogen

  • The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

Select an application
Product promiseTestedExpectedPredictedNot recommended
IPIHC-PFlow CytICC/IFDotWBI-ELISA
Human
Not recommended
Not recommended
Not recommended
Not recommended
Expected
Tested
Expected
Mouse
Not recommended
Not recommended
Not recommended
Not recommended
Predicted
Predicted
Predicted
Rat
Not recommended
Not recommended
Not recommended
Not recommended
Predicted
Predicted
Predicted
Synthetic peptide
Not recommended
Not recommended
Not recommended
Not recommended
Not recommended
Not recommended
Tested
Synthetic peptide - Human
Not recommended
Not recommended
Not recommended
Not recommended
Tested
Not recommended
Not recommended

Not recommended
Not recommended

Species
Human, Mouse, Rat, Synthetic peptide - Human, Synthetic peptide
Dilution info
-
Notes

-

Not recommended
Not recommended

Species
Human, Mouse, Rat, Synthetic peptide - Human, Synthetic peptide
Dilution info
-
Notes

-

Not recommended
Not recommended

Species
Human, Mouse, Rat, Synthetic peptide - Human, Synthetic peptide
Dilution info
-
Notes

-

Not recommended
Not recommended

Species
Human, Mouse, Rat, Synthetic peptide - Human, Synthetic peptide
Dilution info
-
Notes

-

Tested
Tested

Species
Synthetic peptide - Human
Dilution info
1/1000
Notes

-

Expected
Expected

Species
Human
Dilution info
Use at an assay dependent concentration.
Notes

-

Predicted
Predicted

Species
Mouse, Rat
Dilution info
-
Notes

-

Not recommended
Not recommended

Species
Synthetic peptide
Dilution info
-
Notes

-

Tested
Tested

Species
Human
Dilution info
1/10000 - 1/50000
Notes

-

Predicted
Predicted

Species
Mouse, Rat
Dilution info
-
Notes

-

Not recommended
Not recommended

Species
Synthetic peptide - Human, Synthetic peptide
Dilution info
-
Notes

-

Tested
Tested

Species
Synthetic peptide
Dilution info
1000 µg/mL
Notes

-

Expected
Expected

Species
Human
Dilution info
Use at an assay dependent concentration.
Notes

-

Predicted
Predicted

Species
Mouse, Rat
Dilution info
-
Notes

-

Not recommended
Not recommended

Species
Synthetic peptide - Human
Dilution info
-
Notes

-

Associated Products

Select an associated product type

1 product for Alternative Product

Target data

Function

Serine/threonine-protein kinase (PubMed:23666762). Involved in cell polarity and microtubule dynamics regulation. Phosphorylates CRTC2/TORC2, DCX, HDAC7, KIF13B, MAP2, MAP4 and RAB11FIP2. Phosphorylates the microtubule-associated protein MAPT/TAU (PubMed:23666762). Plays a key role in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Regulates epithelial cell polarity by phosphorylating RAB11FIP2. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Regulates axogenesis by phosphorylating KIF13B, promoting interaction between KIF13B and 14-3-3 and inhibiting microtubule-dependent accumulation of KIF13B. Also required for neurite outgrowth and establishment of neuronal polarity. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Modulates the developmental decision to build a columnar versus a hepatic epithelial cell apparently by promoting a switch from a direct to a transcytotic mode of apical protein delivery. Essential for the asymmetric development of membrane domains of polarized epithelial cells.

Additional Targets

MARK3 phospho T234, MARK4 phospho T214, MARK1 phospho T215

Alternative names

Recommended products

Rabbit Recombinant Monoclonal MARK4 phospho T214 + MARK2 phospho T208 + MARK3 phospho T234 + MARK1 phospho T215 antibody. Suitable for Dot, WB, I-ELISA and reacts with Human amd Synthetic peptide samples.

Key facts

Isotype
IgG
Form
Liquid
Clonality
Monoclonal
Immunogen
  • The exact immunogen used to generate this antibody is proprietary information.
Clone number
EPR5463
Purification technique
Affinity purification Protein A
Specificity

This antibody detects MARK4 phosphorylated at Threonine 214, MARK2 phosphorylated at Threonine 208, MARK3 phosphorylated at Threonine 234 and MARK1 phosphorylated at Threonine 215.

Dissociation constant
1.62 x 10-11 M
Concentration
Loading...

Storage

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Notes

Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

5 product images

  • Western blot - Anti-MARK4 (phospho T214) + MARK2 (phospho T208) + MARK3 (phospho T234) + MARK1 (phospho T215) antibody [EPR5463] (ab126731), expandable thumbnail

    Western blot - Anti-MARK4 (phospho T214) + MARK2 (phospho T208) + MARK3 (phospho T234) + MARK1 (phospho T215) antibody [EPR5463] (ab126731)

    Westernblot analysis of ab126731 at a 1/20 dilution. Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (Goat Anti-Rabbit IgG H&L (HRP) ab97051) was used as a scondary antibody at 1/20000 dilution.

    Lane 1: HEK-293 (Human embryonic kidney epithelial cell) transfected with an empty vector (vector control), containing a myc-His-tag®, whole cell lysate 15μg

    Lane 2: HEK-293 transfected with MARK1 expression vector containing a myc-His-tag®, whole cell lysate 15μg

    Lane 3: HEK-293 transfected with MARK1 expression vector containing a myc-His-tag®, whole cell lysate 15μg, then the membrane treated with Alkaline Phosphatase for 1 hour

    Lane 4: HEK-293 transfected with MARK2 expression vector containing a myc-His-tag®, whole cell lysate 15μg

    Lane 5: HEK-293 transfected with MARK2 expression vector containing a myc-His-tag®, whole cell lysate 15μg, then the membrane treated with Alkaline Phosphatase for 1 hour

    Lane 6: HEK-293 transfected with MARK3 expression vector containing a myc-His-tag®, whole cell lysate 15μg

    Lane 7: HEK-293 transfected with MARK3 expression vector containing a myc-His-tag®, whole cell lysate 15μg, then the membrane treated with Alkaline Phosphatase for 1 hour

    Lane 8: HEK-293 transfected with MARK4 expression vector containing a myc-His-tag®, whole cell lysate 15μg

    Lane 9: HEK-293 transfected with MARK4 expression vector containing a myc-His-tag®, whole cell lysate 15μg, then the membrane treated with Alkaline Phosphatase for 1 hour

    Exposure time:

    Lane 1 – 3, 6 - 9: 180 seconds

    Lane 4 - 5: 7 seconds

    Endogenous MARK proteins are observed at ~110 kDa reported by PMID: 9108484 and 16238695

    All lanes: Western blot - Anti-MARK4 (phospho T214) + MARK2 (phospho T208) + MARK3 (phospho T234) + MARK1 (phospho T215) antibody [EPR5463] (ab126731)

  • Indirect ELISA - Anti-MARK4 (phospho T214) + MARK2 (phospho T208) + MARK3 (phospho T234) + MARK1 (phospho T215) antibody [EPR5463] (ab126731), expandable thumbnail

    Indirect ELISA - Anti-MARK4 (phospho T214) + MARK2 (phospho T208) + MARK3 (phospho T234) + MARK1 (phospho T215) antibody [EPR5463] (ab126731)

    Indirect ELISA antibody dose-response curve using ab126731 between 0-10000 ng/ml. Antigen concentration of 500 ng/mL. An alkaline phosphatase-conjugated goat anti-rabbit IgG (H+L) (1/2500) was used as the secondary antibody.

  • Dot Blot - Anti-MARK4 (phospho T214) + MARK2 (phospho T208) + MARK3 (phospho T234) + MARK1 (phospho T215) antibody [EPR5463] (ab126731), expandable thumbnail

    Dot Blot - Anti-MARK4 (phospho T214) + MARK2 (phospho T208) + MARK3 (phospho T234) + MARK1 (phospho T215) antibody [EPR5463] (ab126731)

    Dot Blot using ab126731 at a 1/1000 dilution and Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at a 1/100000 dilution

    Lane 1: Human MARK1 (T215) phospho peptide

    Lane 2: Human MARK1 non-phospho peptide

    Lane 3: Human MARK2 (T208) phospho peptide

    Lane 4: Human MARK2 non-phospho peptide

    Lane 5: Human MARK3 (T234) phospho peptide

    Lane 6: Human MARK3 non-phospho peptide

    Lane 7: Human MARK4 (T214) phospho peptide

    Lane 8: Human MARK4 non-phospho peptide

  • Western blot - Anti-MARK4 (phospho T214) + MARK2 (phospho T208) + MARK3 (phospho T234) + MARK1 (phospho T215) antibody [EPR5463] (ab126731), expandable thumbnail

    Western blot - Anti-MARK4 (phospho T214) + MARK2 (phospho T208) + MARK3 (phospho T234) + MARK1 (phospho T215) antibody [EPR5463] (ab126731)

    All lanes: Western blot - Anti-MARK4 (phospho T214) + MARK2 (phospho T208) + MARK3 (phospho T234) + MARK1 (phospho T215) antibody [EPR5463] (ab126731) at 1/10000 dilution

    Lane 1: SH-SY5Y cell lysate, untreated at 10 µg

    Lane 2: SH-SY5Y cell lysate, treated with Okadaic acid and Calyculin A at 10 µg

    Secondary

    All lanes: HRP labelled goat anti-rabbit at 1/2000 dilution

  • OI-RD Scanning - Anti-MARK4 (phospho T214) + MARK2 (phospho T208) + MARK3 (phospho T234) + MARK1 (phospho T215) antibody [EPR5463] (ab126731), expandable thumbnail

    OI-RD Scanning - Anti-MARK4 (phospho T214) + MARK2 (phospho T208) + MARK3 (phospho T234) + MARK1 (phospho T215) antibody [EPR5463] (ab126731)

    We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody.
    Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com